Loss of L-selectin-guided CD8(+) , but not CD4(+) , cells protects against ischemia reperfusion injury in a steatotic liver.
Loss of L-selectin-guided CD8(+) , but not CD4(+) , cells protects against ischemia reperfusion injury in a steatotic liver.
复制标题
DOI:
10.1002/hep.29276
复制
发表时间:
2017-10
期刊:
影响因子:
--
通讯作者:
Gupta NA
中科院分区:
文献类型:
--
作者:
Kolachala VL;Palle S;Shen M;Feng A;Shayakhmetov D;Gupta NA
Steatotic liver responds with increased hepatocellular injury when exposed to an ischemic-reperfusion insult. Increasing evidence supports the role of immune cells as key mediators of this injury in a normal (lean) state, but data about their role in a steatotic liver are practically non-existent. The objective of the current study was to delineate contribution of specific phenotypes of T cells and adhesion molecules in exacerbated cell death in steatotic liver injury. RNA sequencing was performed on isolated steatotic primary hepatocytes and T cell markers were assessed in hepatic lymphocytes after ischemia reperfusion injury (IRI) in high fat diet (HFD) fed mice. CD8−/− and CD4−/− mice along with CD8 and L-selectin antibody treated mice were fed on a HFD and hepatocellular injury was assessed by histology, propidium iodide injection and ALT after IRI. RNA sequencing demonstrated a strikingly differential gene profile in steatotic hepatocytes vs. lean hepatocytes. After injury, the HFD liver showed increased necrosis, infiltrating CD8+ cells, ALT and proinflammatory cytokines. Hepatic lymphocytes demonstrated increased CD8+/CD62L+(L-selectin) cells in HFD fed mice after IRI. CD8−/− mice and CD8 depleted C57BL/6 mice, demonstrated significant protection from injury, which was not seen in CD4−/− mice. L-selectin blockade also demonstrated significant hepatoprotection from IRI. L selectin ligand MECA-79 was increased in HFD fed mice undergoing IRI. Blockade of CD8 and L-selectin but not CD4, ameliorated hepatocellular injury, confirming that CD8+ cells are critical drivers of injury in a steatotic liver. This represents a novel therapeutic target in steatotic liver injury, underlining the importance of development of therapies specific to a steatotic liver.
登录
查看更多内容
DOI:
10.1097/mpg.0000000000001008
发表时间:
2016-03
影响因子:
2.9
作者:
Kolachala VL;Jiang R;Abramowsky CR;Gupta NA
通讯作者:
Gupta NA
影响因子:
24.5
作者:
Feldstein AE;Charatcharoenwitthaya P;Treeprasertsuk S;Benson JT;Enders FB;Angulo P
通讯作者:
Angulo P
影响因子:
64.8
作者:
GALLATIN, WM;WEISSMAN, IL;BUTCHER, EC
通讯作者:
BUTCHER, EC
DOI:
10.1152/ajpgi.00210.2014
发表时间:
2014-12-01
影响因子:
4.5
作者:
Gupta, Nitika A.;Kolachala, Vasantha L.;Kirk, Allan D.
通讯作者:
Kirk, Allan D.
影响因子:
2.2
作者:
Martinez-Mier, G;Toledo-Pereyra, LH;Ward, PA
通讯作者:
Ward, PA